The FDA granted emergency use authorization for Johnson & Johnson’s coronavirus vaccine on Saturday. The vaccine is the third to receive regulatory approval in the US, joining those made by Pfizer and Moderna. Roughly 4M doses are expected to be distributed this week, and J&J expects to ship 20M doses by the end of the month.
Extra: J&J’s vaccine notably uses a single dose, compared to vaccines from Pfizer and Moderna that require two doses.
The New Paper
This story is from the March 1, 2021 edition of The New Paper – a clear, concise daily briefing that makes fact-first news easy to consume. Try it today.
